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Because of the growing trend toward populations, aging in many countries worldwide, there is an
increased focus on geriatric dermatology. Although skin problems might sometimes seem minor
compared with other major systemic diseases frequently seen in this age group, accurate diagnosis and
proper management help reduce the morbidity and positively inﬂuence their life quality.
Because of various senile changes in skin, elderly people are predisposed to certain dermatological
disorders. The most common cutaneous diseases that will be characterized in this article are broadly
categorized into inﬂammatory dermatoses, cutaneous infections, vascular disorders, and neoplasms.
Management of these cutaneous diseases in elderly population requires particular attention to their
inherent physical and physiological weaknesses and associated complicated problems.
Copyright  2010, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
 
Open access under CC BY-NC-ND license.LLC.1. Physical and physiological changes in elderly skin
As a result of a combination of cumulative intrinsic and extrinsic
aging, skin undergoes considerable changes. Intrinsic aging is
a process of natural senescence, whereas extrinsic factors include
UV-light exposure, smoking, and various environmental insults.
The epidermal turnover rate slows down with age, delaying
reepithelialization time after injury. Older corneocytes accumulate,
imparting a dull gray-white appearance and rough feeling to aging
skin. Altered biosynthesis of stratum corneum lipids, including
ceramides, triglycerides, and fatty acids, may lead to increased
transepidermalwater loss and defects in the permeability barrier.1e3
Besides, decreased epidermal ﬁlaggrin formation reduces natural
moisturizing factor of stratum corneum and its ability to maintain
hydration.1,4 Therefore, dryness of skin, or xerosis, is a common
problem among the elderly. The altered barrier function also
contributes to increased susceptibility to contact irritants or aller-
gens,5 which may be the cause of xerosis-induced pruritus.and Rheumatology, Taichung
-Kang Road, Taichung 40705,
.
Clinical Gerontology & Geriatrics. PThe aging skin shows thinned epidermis and ﬂattening of epi-
dermaledermal junction, which increase the incidence of skin tears
from shearing and friction.With addition of decreased elastic content
in dermis and vasculature, skin becomes easily bruised (senile
purpura). The dermis has disordered, sparse collagen and elastin
ﬁbers, and there is a gradual decrease in nerve endings, microcircu-
lation, and sweat glands, predisposing the elderly to increased risk of
pressureulcers, thermal injury, and longerhealing timeafter injuryor
surgery.6e8 Besides, impaired immune response,which ismanifested
by diminished inﬂammatory reaction, particularly cell-mediated
immunity, may result in increased susceptibility to infection.92. Inﬂammatory dermatoses
Inﬂammatory dermatoses comprise awide arrayof skin diseases,
which account for most of the cutaneous problems in the elderly.2.1. Pruritus
Pruritus is the most common dermatological complaint of the
elderly population, with a prevalence as high as 29% in one study.10
Chronic pritus (>6-week duration) is a distressing symptom of many
cutaneous, systemic, or neuropsychiatric diseases.11 Dermatological
diseases causing pruritus in elderly patients, as shown in a study byublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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ders, lichen simplexchronicus, urticaria, andothers,with xerosis being
the most prevalent (almost 40% of all patients with pruritus). Pruritus
mayoriginate fromdiverseunderlying systemicdiseasesor conditions,
including iron deﬁciency anemia, thyroid disease, diabetes mellitus,
cholestatic liver disease, renal dysfunction, drug reaction, and malig-
nancy. Emotional or psychological stresses, such as depression and
anxiety, may also be contributing factors to itching.10 Nevertheless, in
up to 30% of patients, pruritus remains idiopathic13 and occurs more
frequently and more severely with increasing age.14
Before initiating treatment, thorough skin examination, review of
medication history, and careful diagnostic evaluation and identiﬁca-
tion of any underlying diseases should be conducted. A psychological
evaluation may be necessary in some elderly patients with chronic
pruritus. The underlying causes should be treated accordingly.
Emollients, particularly with additional antipruritic agents, such
as menthol, camphor, phenol, or doxepin, can temporarily reduce
pruritus.15,16 Calamine, oatmeal bath, and chamomile preparations
are also helpful in relieving itching. Oral antihistamines are often
used, supplemented with short-term use of topical or systemic
corticosteroids. Recently, innovative therapies have been developed
targeting new neuronal mechanisms in the skin and brain.17
2.2. Xerosis and asteatotic eczema
Xerosis, or dryness of the skin, is themost common skin disorder
in the elderly.18 As previouslymentioned, increased transepidermal
water loss, reduced sebum and sweat production, and decreased
natural moisturizing factor, all lead to skin dryness.19 In addition,
irregular alignment of corneocytes because of abnormal maturation
and adhesion of keratinocytes results in rough and scaly skin.20
Commonly seen on the lower legs, it is often accompanied by
intense itching, excoriation, or inﬂammatory changes recognized as
asteatotic eczema. Skin may show varying degrees of erythema,
cracking, ﬁssuring, or present with a “crazy paving” appearance.
Extrinsic aggravating factors include low ambient humidity, exces-
sive bathing (especially using harsh soaps or detergents), irritating
clothing, and use of products containing alcohol or acetone. Diuretic
drugs and cholesterol-lowering agents have also been shown to
induce skin dryness.1,21
Treatment for xerosis consists of avoidance of aggravating
factors and hydration of skin. Patients should be advised to bathe
less frequently using a moderate-temperature bath, mild soaps, or
soap substitutes. Application of bath oil helps form a thin ﬁlm of oil
on the body surface. Moisturizers need to be applied immediately
after a bath. Optimal moisturizing products should have both
occlusive and humectant properties.22 Petrolatum, lanolin-based
emollients, or moisturizers containing lactic acid or its salt are
frequently suggested.23 Short-term use of topical corticosteroids
may be needed if inﬂammation or itch is severe.
2.3. Seborrheic dermatitis
Seborrheic dermatitis is commonly seen (but sometimes over-
looked) in the elderly, especially those with neurological disorders,
suchas Parkinson’sdisease, Alzheimer’sdisease, or emotional stress.24
Clinically, faint erythematous patches with greasy scales may be
distributed mainly on areas rich in sebaceous glands, including scalp,
eyebrows, glabella, paranasal fold, postauricular area, and inter-
triginous areas.25Malassezia yeast, a commensalﬂora on human skin,
is implicated in its pathogenesis.26 Abrupt appearance of seborrheic
dermatitis has been reported to be associated with underlying
medical disorders, especially in the elderly.27 Seborrheic dermatitis of
the scalp is usually treated with shampoos containing cytostatic
agents (zinc pyrithione, selenium sulﬁde); keratolytics (salicylic acid);ketokonazole; or tar preparations. Mild topical corticosteroids, calci-
neurin inhibitors and antifungal creams are frequently used for
treatment of seborrheic dermatitis of glabrous skin.
2.4. Nummular dermatitis
Nummular dermatitis, or discoid eczema, is characterized by
pruritic oval- or coin-shaped plaques, which may weep or become
crusted, scaly, or infected, and are often found on lower legs and
forearms. A potassium hydroxide (KOH) examinationmay be helpful
in making the differential diagnosis from tinea corporis. Nummular
dermatitis is often associated with low humidity, xerosis, or
emotional stress.28
Treatmentofnummulardermatitis includes topical corticosteroids,
topical calcineurin inhibitors, and emollients.29 It usually responds
slowly to treatment and runs a chronic course, which is often difﬁcult
to control evenwith potent topical corticosteroid preparations.30
2.5. Contact dermatitis
Contact dermatitis has been reported to occur in as high as 11% of
the elderly population, and includes allergy-and irritant-type reac-
tions.22 Because of its reduced ability to mount delayed hypersen-
sitivity reaction, the elderly skin shows relatively less vesiculation or
inﬂammation and early appearance of scaling, hyperpigmentation,
and licheniﬁcation.31
Certain antimicrobials (i.e., neomycin, nitrofurazone in topical
medications); lanolin; parabens (in topical medications, cosmetics,
or moisturizers); dyes; plants; balsams; rubber; and nickel are
among the most common allergens,31,32 whereas alkaline soaps,
detergents, or cleaners aremore likely the culprits in cases of irritant
dermatitis.33 Patch testing is useful in identifying the allergens.
Treatment starts with avoidance of the causative agents or products
if feasible. Emollients and mild corticosteroids usually sufﬁce for
irritant dermatitis, whereas allergic contact dermatitis often
requires potent topical corticosteroids, oral antihistamines, or
corticosteroids according to its severity.34e36 It is less responsive to
treatment and tends to run amore chronic course in elderly patients
than in younger patients.31
2.6. Drug eruptions
Polypharmacy is common among the elderly population, which
may lead to higher risk of cutaneous adverse drug reactions while
also complicating the effort to pinpoint the culprit.37 Drug reactions
may take the form of almost any dermatological disease, with
exanthema and urticaria being the most common reaction
morphologically.38 Drug exanthems are symmetric erythematous
morbilliform maculopapular eruptions, often associated with
pruritus. They typically occur within 1 week of initiation of a drug
regimen and resolvewithin 2weeks after discontinuation, although
considerable variation exists.39 Wheals and ﬂare reaction are char-
acteristic of urticaria and often vanish rapidly on discontinuation of
medication. To make an accurate diagnosis, careful investigation of
medication history, including over-the-counter or herbal drugs,
should be carried out. Prompt and accurate diagnosis enables early
withdrawal of the inducingdrug,which is critical for the elderlywho
are generally more vulnerable to severe drug reactions.40
3. Cutaneous infection
Infectious skin diseases ranked ﬁrst on the list of diagnostic
categories of skin diseases according to a survey of dermatological
outpatient services in Taiwan.41 Bacterial and fungal infection may
be more prevalent in Taiwan because of its humid and warm
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common fungal infections,41 whereas the most common viral
infection is herpes zoster.
3.1. Bacterial infection
The bacterial infections of skin in the elderly population may
appear atypical in their symptoms and signs. The most common
ones are cellulitis and infected ulcers in this age group.42
Cellulitis is a bacterial infection of the lower dermis and subcu-
taneous soft tissue, most often caused by Staphylococcus aureus or
Group A beta-hemolytic streptococci, presenting with a tender
sharply bordered erythematous warm edematous plaque, some-
times superimposed with vesicles, erosions, hemorrhage, abscess,
or necrosis on the plaque, or accompanied by lymphangitis.43 It
often affects the lower legs,which usually follows interdigital fungal
infection of the feet. The main differential diagnoses are deep vein
thrombosis, allergic contact dermatitis, and stasis dermatitis.44
Routine skin swabs (from open lesions) or aspiration (from
ﬂuctuant lesions or bullae) should be sent for detection of causative
pathogen and tested for antibacterial sensitivity. Initial manage-
ment should be penicillinase-resistant penicillin, such as ﬂuclox-
acillin or dicloxacillin for 10 days.42 More severely ill patients,
particularly thosewithmedical disorders, such as diabetesmellitus,
should be hospitalized and treated. Of note, there has been an
alarming increase in the prevalence ofmethicillin-resistant S. aureus
infection in the past decade, particularly in Taiwan.43 In such cases,
vancomycin, teicoplanin, linezolid, and quinupristin-dalfopristin
are among the drugs of choices.43,45 In addition, it is important that
any abscess collections should be drained or debrided.
3.2. Fungal infections
Tinea pedis and tinea unguium are the most common cutaneous
fungal infections in the elderly population. Intertrigo and paro-
nychia related to Candida are also quite prevalent in this age group.
3.2.1. Tinea pedis
The most commom dermatophytes are Trichophyton rubrum,
Trichophyton mentagrophytes, and Epidermophyton ﬂoccosum.
Dermatophytes often serve as a primary source of dermatophytic
infection that can spread to the nails (tinea unguium), groin (tinea
cruris), trunk (tinea corporis), and hands (tinea manuum). They are
three major clinical types: (1) interdigital, (2) moccasin, and (3)
inﬂammatory/vesiculobullous.46
Diagnosis is conﬁrmed with a KOH preparation (10e20%) and
microscopic examination for hyphae. The specimen should be taken
from dry scale, because macerated scale on the interdigital webs is
often overgrown with bacteria producing antifungal substances.
Fungal cultures are not sensitive but can be helpful if diagnosis of
tinea pedis is still strongly suggested from clinical appearance in
spite of negative KOH examination.
Treatment primarily involves the use of topical antifungal agents,
which include imidazoles (i.e., clotrimazole, sulconizole) and allyl-
amines (i.e., terbinaﬁne, butenaﬁne). Keratolytic agents (salicylic acid,
lactic acid) should also be used to remove hyperkeratosis in
moccasin-type tinea pedis. Twice-daily applications are required for
2e4weeks, includingmore than1week after lesions have resolved.30
Onychomycosis may be a source of reinfection of tinea pedis and
should be treated as well.
The course of tinea pedis tends to be chronic and usually exac-
erbates in hot weather. Because it may also provide portal of entry
for cellulitis or lymphangitis, taking preventive measures is very
important, including use of personal shower shoes while bathing,
thorough drying of feet after bathing, use of antifungal powder(powder containing miconazole or tolnaftate), or washing feet with
benzoyl peroxide bar (i.e., panoxyl bar).30 Intermittent application
of antifungal agents once or twice a week also may be beneﬁcial.
3.2.2. Onychomycosis
Onychomycosis (fungal nail infection) is most often (90%)
caused by dermatophytes, so called tinea unguium. Its prevalence
increases with age.47
There are three main clinical types according to the site of
involvement: (1) distal and lateral subungual onychomycosis,
(2) superﬁcial white onychomycosis, and (3) proximal subungual
onychomycosis. The distal and lateral subungual onychomycosis,
the most common type, shows nail thickening, crumbling, discol-
oration, onycholysis, or subungual hyperkeratosis. It often involves
the great toenails.
For KOH examination or fungal cultures, scraping of soft sub-
ungual debris should be taken from the nail bed and underside of the
most proximally involved nail plate in distal/lateral type onychomy-
cosis. Histopathology with periodic acid-schiff (PAS) stain of nail
clippings is both a sensitive and the most reliable technique for
diagnosis30 but is likely to be negative in proximal subungual and
superﬁcial white onychomycosis.46 It is essential to prove fungal
infection and differentiate fromother nail dystrophies before starting
systemic treatment.
The most commonly used antifungal drugs are terbinaﬁne and
itraconazole. Terbinaﬁne has superior mycological cure rates
comparedwith iraconazole orﬂuconzole.48,49 Thedosage is 250 mg/d
for 6 weeks for ﬁngernails and 12e14 weeks for toenails. It has less
potential for drug interaction and, therefore, is relatively safer for
elderly patients compared with other azoles. However, it has low
efﬁcacy against other fungi.
To prevent relapse, follow-up treatment with topical antifungal
agents may be beneﬁcial. Patients should be advised to discard
their old, moldy footwear; keep feet clean and dry; and use their
own instruments for manicures or pedicures.
3.2.3. Cutaneous candidiasis
Cutaneous candidiasis occurs most commonly at moist occluded
skin sites (intertrigo, angular cheilitis, genital candidiasis, oral
thrush, balanitis or vulvitis, and others) and on nail apparatus
(chronic paranychia). Candida albicans is frequently the pathogen.
Predisposing factors include diabetes mellitus, obesity, system-
ic/topical glucocorticoids, broad-spectrum antibiotics, immunosup-
pressive drugs, and chronic debilitation. Often found in body folds,
such as inframammary areas, groins, axillae, and intergluteal folds,
intertrigo is characterized bywell-marginated erythematous eroded
patches with satellite pustules at the periphery.
Diagnosis is based on clinical ﬁndings and conﬁrmed by direct
microscopy or culture. KOH preparation shows sausage-like pseu-
dohyphe and yeast forms. Topical antifungal treatment (nystatin,
azole, or imidazole cream) is generally effective in the immuno-
competent individuals, but oral antifungal agents (itraconazole,
ﬂuconazole, or ketonazole) are indicated for more resistant cases.
The precipitating factors should be properly dealt with if possible.
The affected areas need to be kept dry and protected from further
maceration with greasy emollients.44 Washing with benzoyl
peroxide bar or daily use of miconazole powder may also be helpful.
Chronic paronychia is now considered chronic dermatitis of the
periungual tissue,50 often complicated by secondary Candida,
Pseudomonas aeruginosa, or S. aureus infection. It is characterized by
painful erythema, edema of the proximal and lateral nail folds, and
deformity of the nail plate. Therefore, in addition to treatment for
secondary infection, management should primarily be aimed at
treating dermatitis with topical or intralesional corticosteroids. It is
also important to reduce exposure to water or other irritants.
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Herpes zoster, alsoknownasshingles, is causedbyvaricella-zoster
virus (VZV) and occurs more commonly in older individuals. After
initial varicella infection, this virus may remain dormant for a long
period of time in the ganglia of the sensory nerve root of the affected
sites. Certain risks factors, most likely reduced cell-mediated
immunity to VZV with advancing age, may reactivate VZV and result
in herpes zoster.
Its associated prodromal pain can be misdiagnosed as other
medical or surgical conditions, such as migraine, acute myocardial
infarction, or acute abdomen, depending on the involved derma-
tomes. Crops of vesicles develop on an erythematous edematous
base in a unilateral, dermatomal distribution. The site of predispo-
sition is thoracic dermatomes (>50%), followed by trigeminal
dermatome (10e20%). Nasociliary involvement of ophthalmic
branch of the trigeminal nerve is often heralded by vesicles near the
nose tip (Hutchinson’s sign) and may result in uveitis, keratitis, or
conjunctivitis. Acute pain can occur before and throughout the
course of skin eruptions.
Antiviral therapy shouldbe institutedwithin72hoursof vesicular
eruptions for immunocompromised patients or patientswith severe
acute pain. VZV is less sensitive to acyclovir treatment than herpes
simplex virus (HSV), and higher doses are needed for treatment.
Early implementation and adequate dosage of antiviral agents will
accelerate the healing of skin lesions, reduce the acute pain, and
prevent postherpetic neuralgia.51Dosage for acyclovir is 800 mg,ﬁve
times a day for 7 days. Another commonly used drug is Valacyclovir,
L-valine ester of acyclovir. It has better oral bioavailability, better
efﬁcacy, and simpler dosing regimen (1 gm, three times per day)
than acyclovir.
Postherpetic neuralgia (PHN), which persists for weeks to years
after skin lesions resolve, is particularly a problem for elderly
patients. The duration and severity of PHN are related to age.52 It is
often associated with prodromal pain or acute pain during the ﬁrst
few days of vesicular eruptions.52 Topical analgesic (indomethacin
with ether); topical anesthetic (5% lidocaine gel or EMLA (Astra-
Zeneca)); oral analgesics; tricyclic antidepressants (amitriptyline,
desipramine); gabapentin; or nerve blocks may be useful in
managing PHN. Prevention by immunization with VZV vaccine is
suggested for elderly or other populations with diminishing VZV-
speciﬁc immunity.4. Vascular disorders
Senile changes in skin vasculature show age-related decrease in
vessel density and reduction of cutaneous blood ﬂow. Decreased
endothelial cell permeability and weakened ability to induce
leukocyte adhesion contribute to compromised immune reaction.53
With increased skin rigidity; decreased elasticity (because of loss of
and biochemical change in collagen, elastin, and dermal ground
substance); as well as impaired inﬂammatory responses, aging skin
is rendered more susceptible to injury and is less capable of under-
going modiﬁcation or repair in response.544.1. Stasis dermatitis and ulceration
Stasis dermatitis or ulceration results from venous insufﬁciency
and venous hypertension related to valvular incompetence.
Contributing factors include hereditary cause, prolonged standing,
obesity, and deep vein thrombosis. Older patients, who often have
vascular abnormality associated with various diseases, such as
arteriosclerosis and diabetes mellitus, are more prone to this
disorder.55Stasis dermatitis,most common in themedial paramalleolar area,
manifests as ill-deﬁned dark erythema, dermatitis, variable scaling,
varicose veins, and edema of feet and ankles. Chronic stage may
show licheniﬁcation, hyperpigmentation, or lipodermatosclerosis.
Excoriation or trauma to the fragile skin may result in painful, well-
marginated ulcers, a debilitating disorder for elderly patients.
Treatment of stasis dermatitis includes the application of mild
topical corticosteroid preparations, controlling edema, leg eleva-
tion, and compression dressings or stockings. Venous ulceration is
often treatedwith astringent soaks (e.g., aluminum acetate solution
or potassium permanganate solution soaks); debridement; or
systemic antibiotics in the case of secondary infection.55,56 Surgical
treatment for varicose veins may be indicated.
4.2. Pressure ulcers
Pressure ulcers, also known as decubitus ulcers, or bedsores, are
more commonly seen in elderly patients, especially those with
long-term immobilization, sensory impairment, comorbidity,
malnutrition, or circulatory disorders.57 These risks factors should
be thoroughly evaluated for the patients. Bony prominences,
particularly on the lower portion of the body are the sites of
predilection. Prolonged pressure on tissue leads to ischemia and
further tissue damage. It should be noted that tissue damage starts
from deep in the muscleebone interface; hence, an apparently
small ulcer may turn out to be a much deeper or more extensive
ulcer after debridement. For better detection, evaluation with
palpation is helpful. Management of pressure ulcers should include
treating associated medical conditions; relief of pressure or friction
(e.g., position/mobilization techniques, using pressure-reducing
devices, and frequent repositioning); and wound care (including
debridement, dressings, and control of bacterial infection).
5. Neoplasms
Both benign and malignant tumors are more frequently seen in
elderly population. Common types of benign tumors include
seborrheic keratosis, skin tags, solar lentigines, and cherry angioma.
As to skin malignancy, nonmelanotic tumors, such as basal cell
carcinoma, are the most common types in the elderly patients in
Taiwan.
5.1. Benign tumors
Seborrheic keratosis is the most common type of benign tumors
of epithelial origin. Usually seen after the age of 30 years, seborrheic
keratosis presents aswell-circumscribed tan to brownish papules or
plaques with a greasy feel to its surface and often occurs on face,
trunk, and upper extremities. For atypical or symptomatic lesions,
curettage or punch biopsy may be needed to differentiate from
Bowen’s disease, basal cell carcinoma, or malignant melanoma.
A skin tag, also called acrochordons or soft ﬁbroma, is a soft,
skin-colored to brownish, round or pedunculated, ﬁbroepithelial
polyp. Increasingly commonwith aging, it often occurs on the neck
and in the intertrigionous regions. Treatment includes removal
with scissors, electrodessication, and cryotherapy.
Solar letigines manifest as pigmented macules on sun-exposed
areas and are more common in fair-skinned people. They are
indicators of sensitivity or excessive exposure to UV rays, and
patients should be advised to take measures to reduce sun expo-
sure. Atypical ones should be examined for the presence of lentigo
maligna.
Cherry angiomas, also named senile angiomas, are bright red,
dome-shaped papules, which are mainly distributed on the trunk
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dye laser, is usually not required unless for cosmetic reason.
5.2. Malignancy
The most common malignant tumor is basal cell carcinoma,
which usually arises in the elderly. It typically presents as a pearly
erythematous papule or plaque with rolled border and telangiec-
tasia on the face and neck. Necrosis, ulceration with crusting, or
pigmentation may occur. For lesions in the “danger zone” (central
face, around the eyes, and postauricular sulcus), there is a major
concern about deep invasion and extensive destruction of muscle
and bone. Early removal with Mohs surgery (microscopically
controlled surgery) is the best strategy for such cases. For small and
shallow lesions, treatment options include topical 5-ﬂuorouracil,
imiquimod, excision, cryotherapy, electrodessication, or photody-
namic therapy.
6. Conclusion
Although many common skin diseases occur in younger age
groups, there are certain concerns pertaining to the elderly patients
in the management of such diseases. The elderly may either have
difﬁculty presenting the symptoms or tend to show atypical
symptoms and signs, such as less noticeable fever and leukocytosis
in infectious diseases. Those factors may delay or complicate an
accurate diagnosis. Management of cutaneous disorders should
take into account the patients physiological characteristics, medical
comorbidity, polypharmacy, and social circumstances. Poor
compliance with treatment caused by physical or mental disabil-
ities (impaired vision/hearing, dementia, or immobility) is another
problem for elderly patients. Simple regimens and mild topical
preparations should be prescribed whenever possible for the
purpose of better compliance and reduction of safety concerns.
Patients, perhaps with the help of caregivers, also need to be
reminded to apply the medications correctly and receive moni-
toring as needed.
With better knowledge of and more attention to dermatological
problems in elderly patients, we have a greater chance to help
relieve their discomfort, particularly annoying pruritus or pain, and
promote their well-being.
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